Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins

被引:74
|
作者
Patel, D
Incassati, A
Wang, N
McCance, DJ [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA
[2] Univ Rochester, Dept Biomed Genet, Rochester, NY USA
[3] Univ Rochester, Dept Pathol, Rochester, NY 14627 USA
[4] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
关键词
D O I
10.1158/0008-5472.CAN-03-2917
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus type 16 proteins E6 and E7 have been shown to cause centrosome amplification and lagging chromosomes during mitosis. These abnormalities during mitosis can result in missegregation of the chromosomes, leading to chromosomal instability. Genomic instability is thought to be an essential part of the conversion of a normal cell to a cancer cell. We now show that E6 and E7 together cause polyploidy in primary human keratinocytes soon after these genes are introduced into the cells. Polyploidy seems to result from a spindle checkpoint failure arising from abrogation of the normal functions of p53 and retinoblastoma family members by E6 and E7, respectively. In addition, E6 and E7 cause deregulation of cellular genes such as Plk1, Aurora-A, cdk1, and Nek2, which are known to control the G(2)-M-phase transition and the ordered progression through mitosis.
引用
收藏
页码:1299 / 1306
页数:8
相关论文
共 50 条
  • [1] Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16
    Sashiyama, H
    Shino, Y
    Kawamata, Y
    Tomita, Y
    Ogawa, N
    Shimada, H
    Kobayashi, S
    Asano, T
    Ochiai, T
    Shirasawa, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (01) : 97 - 103
  • [2] Human papillomavirus type 16 E2 and E6/E7 variants
    Swan, DC
    Rajeevan, M
    Tortolero-Luna, G
    Follen, M
    Tucker, RA
    Unger, ER
    GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 695 - 700
  • [3] Human papillomavirus: E6 and E7 oncogenes
    Boulet, Gaele
    Horvath, Caroline
    Broeck, Davy Vanden
    Sahebali, Shaira
    Bogers, Johannes
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11): : 2006 - 2011
  • [4] Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes
    DeFilippis, VR
    Ayala, FJ
    Villarreal, LP
    JOURNAL OF MOLECULAR EVOLUTION, 2002, 55 (04) : 491 - 499
  • [5] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Wlazlo, AP
    Deng, HY
    Giles-Davis, W
    Ertl, HCJ
    CANCER GENE THERAPY, 2004, 11 (06) : 457 - 464
  • [6] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Anthony P Wlazlo
    Hongying Deng
    Wynetta Giles-Davis
    Hildegund C J Ertl
    Cancer Gene Therapy, 2004, 11 : 457 - 464
  • [7] Evidence of Diversifying Selection in Human Papillomavirus Type 16 E6 But Not E7 Oncogenes
    Victor R. DeFilippis
    Francisco J. Ayala
    Luis P. Villarreal
    Journal of Molecular Evolution, 2002, 55 : 491 - 499
  • [9] Extended lifespan and immortalization of normal human fibroblasts by introduction of human papillomavirus (HPV) type 16 E6, E7 or E6/E7 gene.
    Yamamoto, A
    Kumakura, S
    Uchida, M
    Annab, L
    Barrett, JC
    Tsutsui, T
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 872 - 872
  • [10] Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women
    Sethi, S
    Müller, M
    Schneider, A
    Blettner, M
    Smith, E
    Turek, L
    Wahrendorf, J
    Gissmann, L
    Chang-Claude, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (02) : 360 - 364